Updated on: October 15, 2018

2019 CPT® Coding for Skin Biopsies

By
Original story posted on: September 17, 2018

  • Product Headline: 2019 ICD-10-PCS/CM Workshop Series: Express Lane to Coding Proficiency
  • Product Image: Product Image
  • Product Description:
    NOW AVAILABLE 
    ON-DEMAND
Skin biopsy codes are changing.

EDITOR’S NOTE: This is an updated version of the second installment in a two-part series on the 2019 CPT® codes released recently by the American Medical Association.

For many years we have used two codes to report skin biopsies. CPT® 11100 for the first lesion and 11101 for each additional lesion biopsied after the first lesion on the same date of service.
These codes included all methods of removal. The new code ranges are CPT 11102-11107 and are reported based on method of removal which allows for greater specificity. New guidelines were created to help with coding and reporting of these codes. The new CPT codes are as follows:
11102 Tangential biopsy of skin (e.g., shave, scoop, saucerize, curette) single lesion
+ 11103 each separate/additional lesion (List separately in addition to code for primary procedure)
11104 Punch biopsy of skin (including simple closure, when performed) single lesion
+11105 each separate/additional lesion (List separately in addition to code for primary procedure
11106-iincisional biopsy of skin (e.g., wedge) (including simple closure, when performed) single lesion
+11107 each separate/additional lesion (List separately in addition to code for primary procedure

Biopsies are used to obtain tissue for diagnostic histopathologic examination performed independently, or unrelated or distinct from other procedures/services. When a skin lesion is entirely removed, either by excision or shave removal and sent to pathology for examination, it is not considered a biopsy for coding purposes but an excision and should be reported with the excision codes not biopsy CPT codes. When a biopsy is performed on different lesions or different sites on the same day, each biopsy may be performed separately as they are not considered components of other procedures.


The CPT Guidelines state: “Partial-thickness biopsies are those that sample a portion of the thickness of skin or mucous membrane and do not penetrate below the dermis or lamina propria, full-thickness biopsies penetrate tissue deep to the dermis or lamina propria, into the subcutaneous or submucosal space.


Sampling of stratum corneum only, by any modality (e.g., skin scraping, tape stripping) does not constitute a skin biopsy procedure and is not separately reportable. An appropriate biopsy technique is selected based on optimal tissue-sampling considerations for the type of neoplastic, inflammatory, or other lesion requiring a tissue diagnosis”.


Prior to the new CPT codes for 2019, biopsies were reported with CPT code 11100 for the first lesion and 11101 for each additional lesion biopsied regardless of method of removal.
The new biopsy codes are reported based on method of removal including:

  • Tangential biopsy (11102 and 11103)
  • Punch biopsy (11104 and 11105)
  • Incisional biopsy (11106 and 11107


Tangential Biopsy
A tangential biopsy (11102/11103) includes removal via shave, scoop, saucerization or curette. This type of biopsy is performed with a sharp blade such as a flexible biopsy blade, obliquely oriented scalpel or curette. A sample of epidermal tissues is removed with our without portions of the underlying dermis. This type of biopsy does not involve the full thickness of the dermis. When the full thickness of the dermis is involved the procedure reported is 11300-11313 (removal of epidermal or dermal lesions).


Punch Biopsy
A punch biopsy required a punch tool to remove a full thickness cylindrical sample of the skin. The intent of the biopsy is to remove a sample of a cutaneous lesion for a diagnostic pathologic examination. Simple closure is include and cannot be billed separately.


Incisional Biopsy
An incisional biopsy requires the use of a sharp blade (not a punch tool) to remove a full-thickness sample of tissue via a vertical incision or wedge, penetrating deep to the dermis, into the subcutaneous space. An incisional biopsy may sample subcutaneous fat. A simple closure is included with an incisional biopsy even though closure is typically performed. When the entire lesion is excised report the excision codes, 11400-11646 depending on type of lesion (benign or malignant).

Multiple Biopsies
Biopsies are selected by method of removal. If more than one biopsy is performed on the same date, only one primary biopsy code is reported. When more than one biopsy is performed using the same technique, the appropriate primary biopsy code is reported for the first biopsy and the add-on code is reported for each additional lesion.

Example #1: A physician performed biopsies on a patient with two suspicious lesions, one on the left arm and one on the left leg via shave technique. The encounter is coded as:
CPT coding:
1. 11102 (tangential biopsy of skin) 1st lesion
2. 11103 (tangential biopsy of skin, each additional lesion) 2nd lesion

When two biopsies are performed using two different techniques, report the primary code and the-add on code based on type of biopsy performed.

Example #2: A physician performed a punch biopsy of the chest and an incisional biopsy of the left arm.
CPT coding:
1. 11106 (incisional) 1st lesion
2. 11105 (punch biopsy each additional lesion) 2nd lesion

Example #3: A physician performed a shave biopsy on the left arm and leg and a punch biopsy on the chest.
CPT coding:
1. 11104 (punch biopsy) 1st procedure,
2. 11103 (shave biopsy, each additional lesion, leg) 2nd procedure
3. 11103 (punch biopsy, each additional lesion chest) 3rd procedure


Conclusion
Make sure you document method of removal and anatomic site. Remember all excision codes include a biopsy so a separately biopsy code on the same structure is not appropriate. If an excision is performed even if the specimen is sent to pathology report an excision code. Report one code per lesion biopsied. When multiple biopsies are performed via different methods, report one primary code and use an-add on based on biopsy method for each additional biopsy on the same date.

Deborah Grider, CPC, CPC-H, CPC-I, CPC-P, CPMA, CEMC, CCS-P, CDIP, Certified Clinical Documentation Improvement Practitioner

Deborah Grider has 34 years of industry experience and a recognized national speaker, consultant and American Medical Association Author who has been working with ICD-10 since 1990 and is the author or Preparing for ICD-10, Making the Transition Manageable, Principles of ICD-10 and the ICD-10 Workbook, Medical Record Auditor, and Coding with Modifiers for the AMA. She is a senior healthcare consultant with Karen Zupko & Associates. Deborah is also the 2017 American Health Information Management Literacy Legacy Award Recipient. She is a member of the ICD10monitor editorial board and a popular panelist on Talk Ten Tuesdays.

Related Stories

  • ICD-10 Coding: Moderate “Conscious” Sedation vs. “Monitored” Sedation – Are you compliant?
    Coders must ensure documentation supports the service, either moderate sedation or MAC. Coding moderate sedation (or conscious sedation) and monitored anesthesia care (MAC) is not difficult; however, distinguishing what the services provided are and deciphering conflicted information about which physicians…
  • Major Challenges Face Coders in 2019 and Beyond
    Address documentation and coding issues up front, rather than correct them later. Coders have had many challenges throughout the years.  When I started in the industry, we did not submit claims electronically; they were submitted on paper and we used…
  • Telehealth and the Impact of ICD-10-CM
    CMS announced on Friday a proposed rule to expand telehealth access for patients. Hospitals, doctors, and other providers seeking an edge in today’s highly competitive healthcare environment would do well to consider a smart telehealth strategy. It’s not an option…